Exclusive Speaker Interview: Erin Krolikiewicz at Roche

Get a first look at how global pharma leaders are building stronger talent pipelines and developing the executives of tomorrow.

At CLO Exchange Healthcare & Life Sciences, Erin Krolikiewicz, Global Head of Pharma Talent Strategy at Roche, shares how foundational leadership programs, strategic career architecture, and accelerated capability development are driving succession planning for critical roles across global pharma.

In this exclusive interview, Erin breaks down the real challenges of scaling learning programs across a global workforce, why prescriptive development matters for leaders on a succession track, and where organizations should be investing in talent over the next 12–18 months.

Key Insights:

• Why increasing participation in foundational leadership programs is essential to succession strategy
• How to embed learning and development into architected career plans for high-potential talent
• The challenge of balancing learner capacity, prescriptive development, and democratized program access
• Why accelerated skills development for specific roles and functions is a near-term investment priority
• How to build long-term leadership development pathways for those assessed for expanded executive roles

Join senior learning and talent leaders for closed-door discussions on what's working right now in workforce development, succession planning, and talent strategy across healthcare and life sciences.

Don't miss the opportunity to connect with Erin Krolikiewicz and other top learning leaders at CLO Exchange Healthcare & Life Sciences, May 3–5, 2026, at the Royal Sonesta Boston.